Immune-modulating-cancer

Molecular Mechanism of Autophagy in Cancer Immune Escape

Immunotherapies appear to give some promising clinical outcomes in patients with advanced and metastatic cancer that are ... highlighted in tumor immunity. Autophagy appears to regulate the immune ... read more

UCLA researchers advance cancer treatment aiming to target tumors

UCLA researchers developed a new cancer treatment that could be useful for targeting solid tumors. In the study, the researchers said they developed a biodegradable scaffold that is implanted near ... read more

IO Biotech Provides Business Update

NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® vaccine ... read more

Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia

Researchers evaluated the clinical and genetic characteristics of acute myeloid leukemia (AML) patients with a mutant Ikaros zinc finger protein 1 (IKZF1). read more

IO Biotech Provides Business Update

NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® vaccine ... read more

Bacteria play specific roles in cancer

In a recent article published in the journal Immunity, the authors discussed the findings from a 2022 study by Galeano Niño et al., which reported that microbiota associated with tumors form ... read more

The role of gut microbiota in cancer treatment: friend or foe?

cuhk.edu.hk The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint ... read more

IO Biotech Provides Business Update

The level of enthusiasm from leading cancer institutions around the world to work with our novel, investigational immune-modulating vaccine we believe is a testament to the potential broad ... read more

IO Biotech Announces Appointment of Devin Smith as General Counsel

Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in the life science industriesNEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a ... read more

AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

dostarlimab plus chemotherapy is in the pivotal COSTAR Lung Phase 3 trial in advanced non-small cell lung cancer in patients who have progressed ... It is developing immune cell modulating antibodies, ... read more

Related Blogs:

Cancer Immune Biotech Modulating Clinical Vaccine Developing Microbiota Newswire Patients Researchers Nasdaq Immune Modulating Biotech Nasdaq Globe Newswire





Real Time RSS Feeds | Disclaimer | Contact Us